xCures partners with FibroFighters to launch a real-time learning platform for Fibrolamellar Hepatocellular Carcinoma
Collection and analysis of real-time data about Fibrolamellar aim to deliver essential information for doctors and patients about this rare form of liver cancer Today, xCures announced their collaboration with the FibroFighters Foundation to launch a real-time learning platform for the Fibrolamellar Hepatocellular Carcinoma (FLHCC) community. FLHCC is a rare cancer primarily affecting adolescents and […]
xCures partners with CureScience to make leading translational research available to advanced cancer patients
Doctors and patients will benefit from the integration of xCures’ patient-oriented tracking infrastructure and CureScience’s precision medicine tools Today, xCures announced its partnership with CureScienceTM so that patients across the US can have access to leading translational science approaches through a decentralized clinical research platform. The xCures platform will track outcomes and clinical endpoints to […]
xCures launches xACCESS for Providers
A.I.-assisted portal makes it easier for healthcare providers to enroll cancer patients in managed access programs Today, xCures Inc. launched xACCESS for Providers – a portal for their artificial intelligence (A.I.)-assisted clinical study platform. The HIPAA-compliant portal enables healthcare providers to easily enroll patients in one of xCures’ managed access programs. Typically, to enroll patients […]
xCures announces collaboration with CancerCompass to better support patients and caregivers through their cancer journey
Today, xCures announced their collaboration with CancerCompass, allowing consumers who contact CancerCompass to access the xCures’ platform and services. “xCures partnering with CancerCompass is a significant step toward improving access to personalized knowledge about advanced cancer treatment options,” stated Mika Newton, xCures’ CEO. “This is important progress in our mission to broaden the availability of […]
xCures Joins Decentralized Trials & Research Alliance (DTRA) to Democratize and Accelerate Clinical Trials
New Global Industry Coalition Aims to Dramatically Increase Access for All Patients Populations in Clinical Trials and Research December 23, 2020 – xCures joins a historic alliance of fifty life sciences and healthcare organizations that seeks to accelerate the broad adoption of patient-focused, decentralized clinical trials and research. The “Decentralized Trials & Research Alliance (DTRA),” […]
xCures launches xACCESS – A new module in their AI-assisted clinical platform
The new registration module facilitates expanded access to novel therapies for patients with advanced cancer while accelerating the generation of real-world data on safety and efficacy. SAN FRANCISCO, CA, NOVEMBER 17. Today, xCures Inc. is launching xACCESS – a new registration module for their AI-assisted clinical study platform. The module is used to enroll cancer […]
xCures announces the launch of a Compassionate Use program for ulixertinib (BVD-523)
BioMed Valley Discoveries’ first-in-class ERK inhibitor available through newly opened compassionate use protocol. September 28, 2020 – San Francisco, CA. – xCures, a clinical study platform provider, announces the US Food and Drug Administration (FDA) granted their IND for an intermediate Expanded Access Program (EAP) for the ERK inhibitor ulixertinib (BVD-523). Ulixertinib is being developed by […]
xCures together with Cancer Commons and a confidential partner, to launch a virtual medical food trial in patients with pancreatic cancer
San Francisco, CA, September 23, 2020. Today, xCures Inc., together with a confidential partner, is pleased to announce their launch of a medical food clinical trial. This study, to be led by Jennifer R. Grandis, M.D., aims to characterize a highly engineered medical food formulation as a foundation or component for treatment of patients with […]
BEAT19 crowd-sourcing study jump starts data collection for research to find effective treatments in battle against COVID-19
– 240 million Americans can play a vital role in the search for a vaccine or treatment by contributing critical data from home – SAN FRANCISCO – April 15, 2020 – xCures, a health technology company focused on the use of artificial intelligence, has released preliminary data from the company’s Behavior, Environment, And Treatments for […]